Submission Details
| 510(k) Number | K920895 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 26, 1992 |
| Decision Date | June 04, 1992 |
| Days to Decision | 99 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
K920895 is an FDA 510(k) clearance for the DADE(R) PROTHROMBIN FRAGMENT F1.2 ELISA, a Prothrombin Fragment 1.2 (Class II — Special Controls, product code MIF), submitted by Baxter Diagnostics, Inc. (Miami, US). The FDA issued a Cleared decision on June 4, 1992, 99 days after receiving the submission on February 26, 1992. This device falls under the Hematology review panel. Regulated under 21 CFR 864.7320.
| 510(k) Number | K920895 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 26, 1992 |
| Decision Date | June 04, 1992 |
| Days to Decision | 99 days |
| Submission Type | Traditional |
| Review Panel | Hematology (HE) |
| Summary | Summary PDF |
| Product Code | MIF — Prothrombin Fragment 1.2 |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 864.7320 |